Loading clinical trials...
Loading clinical trials...
A Phase III, Randomized, Multicenter, Double-Blind, Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)
Conditions
Interventions
Ferumoxytol
FCM
Locations
127
United States
Clinical Trial Site
Huntsville, Alabama, United States
Clinical Trial Site
Tucson, Arizona, United States
Clinical Trial Site
Tucson, Arizona, United States
Clinical Trial Site
Anaheim, California, United States
Clinical Trial Site
Chula Vista, California, United States
Clinical Trial Site
Corona, California, United States
Start Date
February 29, 2016
Primary Completion Date
January 16, 2017
Completion Date
July 17, 2017
Last Updated
July 25, 2023
NCT05836961
NCT06642337
NCT06631612
NCT07394088
NCT06238895
NCT03944733
Lead Sponsor
AMAG Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions